Vimarsana
Biggest News Aggregation in the World

Mildredd Perez News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Mildredd Perez. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Mildredd Perez Today - Breaking & Trending Today

Study: Individuals recovering from COVID-19 helpful for Sustained cellular immune dysregulation - Vimarsana News

Study: Individuals recovering from COVID-19 helpful for Sustained cellular immune dysregulation

Study: Individuals recovering from COVID-19 helpful for Sustained cellular immune dysregulation ANI | Updated: Jan 03, 2021 22:10 IST Birmingham [UK], January 3 (ANI): A recent study has determined that Covid-19 patients might be helpful for clinicians to better understand how the unknown SARS-CoV-2 virus acts. According to a study published in the Journal of Clinical Investigation, many infected patients remain asymptomatic or have mild symptoms. Others, especially those with comorbidities, can develop severe clinical disease with atypical pneumonia and ...

Source: aninews.in
Study finds sustained cellular immune dysregulation in patients recovering from COVID-19 - Vimarsana News

Study finds sustained cellular immune dysregulation in patients recovering from COVID-19

Study finds sustained cellular immune dysregulation in patients recovering from COVID-19 ANI | Updated: Jan 02, 2021 23:14 IST Birmingham [UK], January 2 (ANI): Findings from recent researches on COVID-19 and observational clinical research of COVID-19 patients can help clinicians explore more about the virus to better inform treatment and vaccine design. The University of Alabama at Birmingham researchers, led by first-author Jacob "Jake" Files and co-senior authors Nathan Erdmann, M.D., PhD, and Paul Goepfert, M.D., have now reported their observational...

Source: aninews.in
Sustained cellular immune dysregulation in individuals recovering from COVID-19 - Vimarsana News

Sustained cellular immune dysregulation in individuals recovering from COVID-19

Jacob “Jake” Files COVID-19, which has killed 1.7 million people worldwide, does not follow a uniform path.  Many infected patients remain asymptomatic or have mild symptoms. Others, especially those with comorbidities, can develop severe clinical disease with atypical pneumonia and multiple system organ failure.  Since the first cases were reported in December 2019, the SARS-CoV-2 virus that causes COVID-19 has surged into a pandemic, with cases and deaths still mounting. Ongoing observational clinical research has become a priority to better understand how this previously unknown viru...

Source: uab.edu